These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 27989827

  • 21. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P, Liu Z, Sun Y, Ou N, Hu Y, Liu J, Wu Y, Wang D.
    Int J Pharm; 2019 Jan 10; 554():72-80. PubMed ID: 30399435
    [Abstract] [Full Text] [Related]

  • 22. Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities.
    Hanagata N, Li X, Chen MH, Li J, Hattori S.
    Int J Nanomedicine; 2018 Jan 10; 13():43-62. PubMed ID: 29317815
    [Abstract] [Full Text] [Related]

  • 23. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM, Alkie TN, Abdelaziz KT, Hodgins DC, Novy A, Nagy É, Sharif S.
    Viral Immunol; 2016 Jun 10; 29(5):269-75. PubMed ID: 27077969
    [Abstract] [Full Text] [Related]

  • 24. Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.
    Andrews CD, Provoda CJ, Ott G, Lee KD.
    Bioconjug Chem; 2011 Jul 20; 22(7):1279-86. PubMed ID: 21612239
    [Abstract] [Full Text] [Related]

  • 25. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G, Benjamin P, Soita H, Babiuk LA.
    Vaccine; 2008 May 23; 26(22):2680-8. PubMed ID: 18430493
    [Abstract] [Full Text] [Related]

  • 26. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D, Somani VK, Aggarwal S, Bhatnagar R.
    Mol Immunol; 2015 Dec 23; 68(2 Pt A):272-9. PubMed ID: 26442664
    [Abstract] [Full Text] [Related]

  • 27. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y, Wakita D, Chamoto K, Narita Y, Tsuji T, Takeshima T, Gyobu H, Kawarada Y, Kondo S, Akira S, Katoh H, Ikeda H, Nishimura T.
    Cancer Res; 2004 Dec 01; 64(23):8754-60. PubMed ID: 15574787
    [Abstract] [Full Text] [Related]

  • 28. Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice.
    Wen ZS, Xu YL, Zou XT, Xu ZR.
    Mar Drugs; 2011 Dec 01; 9(6):1038-1055. PubMed ID: 21747747
    [Abstract] [Full Text] [Related]

  • 29. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G, Hathout RM, Nasr M, Nejadnik MR, Tu J, Koning RI, Koster AJ, Slütter B, Kros A, Jiskoot W, Bouwstra JA, Mönkäre J.
    J Control Release; 2017 Nov 28; 266():109-118. PubMed ID: 28943194
    [Abstract] [Full Text] [Related]

  • 30. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.
    Martínez Gómez JM, Fischer S, Csaba N, Kündig TM, Merkle HP, Gander B, Johansen P.
    Pharm Res; 2007 Oct 28; 24(10):1927-35. PubMed ID: 17541735
    [Abstract] [Full Text] [Related]

  • 31. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M, Eskandari M, Kharazizadeh M, Khamesipour A, Jaafari MR.
    Trop Biomed; 2010 Dec 28; 27(3):639-50. PubMed ID: 21399606
    [Abstract] [Full Text] [Related]

  • 32. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Mochizuki S, Morishita H, Kobiyama K, Aoshi T, Ishii KJ, Sakurai K.
    J Control Release; 2015 Dec 28; 220(Pt A):495-502. PubMed ID: 26562685
    [Abstract] [Full Text] [Related]

  • 33. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
    Vasilakos JP, Smith RM, Gibson SJ, Lindh JM, Pederson LK, Reiter MJ, Smith MH, Tomai MA.
    Cell Immunol; 2000 Aug 25; 204(1):64-74. PubMed ID: 11006019
    [Abstract] [Full Text] [Related]

  • 34. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P, Wusiman A, Zhang Y, Liu Z, Bo R, Hu Y, Liu J, Wang D.
    Mol Pharm; 2019 Dec 02; 16(12):5000-5012. PubMed ID: 31621331
    [Abstract] [Full Text] [Related]

  • 35. Synergistic stimulation of antigen presenting cells via TLR by combining CpG ODN and poly(γ-glutamic acid)-based nanoparticles as vaccine adjuvants.
    Shima F, Uto T, Akagi T, Akashi M.
    Bioconjug Chem; 2013 Jun 19; 24(6):926-33. PubMed ID: 23631730
    [Abstract] [Full Text] [Related]

  • 36. Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.
    Toda T, Yoshino S.
    Int J Immunopathol Pharmacol; 2016 Sep 19; 29(3):408-20. PubMed ID: 27343242
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.
    Diwan M, Tafaghodi M, Samuel J.
    J Control Release; 2002 Dec 13; 85(1-3):247-62. PubMed ID: 12480329
    [Abstract] [Full Text] [Related]

  • 38. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF, Wang CC, Wu TC, Chu CH, Peng HJ.
    Ann Allergy Asthma Immunol; 2007 Nov 13; 99(5):443-52. PubMed ID: 18051215
    [Abstract] [Full Text] [Related]

  • 39. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.
    Oumouna M, Mapletoft JW, Karvonen BC, Babiuk LA, van Drunen Littel-van den Hurk S.
    J Virol; 2005 Feb 13; 79(4):2024-32. PubMed ID: 15681404
    [Abstract] [Full Text] [Related]

  • 40. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.
    Inoue J, Aramaki Y.
    Vaccine; 2007 Jan 22; 25(6):1007-13. PubMed ID: 17049678
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.